UK markets open in 5 hours 57 minutes

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
81.05-0.45 (-0.55%)
At close: 03:48PM CET
Full screen
Previous close81.50
Open80.05
Bid79.90 x 20000
Ask80.70 x 20000
Day's range80.05 - 81.05
52-week range52.00 - 141.20
Volume65
Avg. volume422
Market cap1.682B
Beta (5Y monthly)0.73
PE ratio (TTM)48.80
EPS (TTM)1.66
Earnings dateN/A
Forward dividend & yield0.45 (0.55%)
Ex-dividend date03 Jun 2021
1y target estN/A
  • EQS Group

    ​​​​​​​Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

    Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Joint Venture​​​​​​​Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-17610-Jan-2022 / 19:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Berlin, 10 January 2022. Eckert & Ziegler Radiopharma GmbH (EZR), the radiopharma

  • EQS Group

    ​​​​​​​Eckert & Ziegler Acquires Argentinian SPECT Specialist

    Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Takeover/Strategic Company Decision ​​​​​​​Eckert & Ziegler Acquires Argentinian SPECT Specialist 03-Jan-2022 / 16:50 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Berlin, 3 January 2022. Eckert & Ziegler has acquired 100% of the shares of Argentinian nuclea

  • EQS Group

    Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application

    DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Study30.11.2021 / 10:55 The issuer is solely responsible for the content of this announcement.Berlin / Toronto, 30 November 2021. Eckert & Ziegler Group is pleased to announce their partnership today with the Canadian Molecular Imaging Probe Consortium (CanProbe), a leader in the advancement and commercialization of novel radiopharmaceuticals to better serve patients and with the University Health Network (UHN), Canada's